肝脏疾病中的心房脉:流行病学和可能的病理生理机制
Lavinia Alice Bălăceanu1,2, Cristiana Grigore1,2, Beatrice Bălăceanu-Gurău3
1Department of Medical Semiology, "Sf. Ioan" Clinical Emergency Hospital, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Journal of clinical medicine
|February 13, 2026
概括
肝病在心房动 (AF) 患者中很常见,特别是与代谢功能障碍相关的脂肪性肝病. 这凸显了AF和肝脏疾病综合管理的必要性.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 心房动 (AF) 经常与心脏代谢疾病同时发生.
- 在AF和肝脏疾病之间存在着强烈的联系,特别是与代谢功能障碍相关的脂肪性肝病 (MASLD).
- 这种AF与肝脏疾病相关的临床特征和影响需要进一步阐明.
研究的目的:
- 在被诊断患有偏激性AF的患者中表征肝脏参与.
- 将文献审查结果与原始临床数据相结合.
- 在AF患者中识别特定的肝脏表型及其临床关联.
主要方法:
- 对253名患有阳性肌前膜炎的患者 (2015-2025) 的回顾性分析.
- 收集人口统计数据和诊断,重点关注肝病理.
- 根据肝病存在/类型的分层,使用统计分析来找到预测因素.
主要成果:
- 在65.2%的AF患者中存在肝脏疾病;肝脏肥胖症 (46.2%) 和肝硬化 (19.0%) 是最常见的.
- 肝脏疾病与较高的2型糖尿病,脂质失调,肥胖和酒精使用率有关.
- 脱脂症和肥胖独立预测肝硬化;肝硬化与年龄和脂质相反相关.
结论:
- 肝病理在 Paroxysmal AF 患者中非常普遍.
- 在AF中,肝脏疾病与不良的代谢和临床特征有关.
- 识别肝脏表型可以改善AF患者的风险分层和风险管理.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
210
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
210
Amyloid Fibrils
12.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Peptic Ulcer Disease II: Pathophysiology
2.2K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.2K
Coronary Artery Disease II: Pathophysiology
540
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
540
Diseases of the Liver and Gallbladder
2.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
1.7K
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
1.7K


